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Targeted disruption of the Nijmegen breakage syndrome gene
NBS1 leads to early embryonic lethality in mice
Jie Zhu*, Simone Petersen*, Lino Tessarollo† and Andre´ Nussenzweig*
Nijmegen breakage syndrome (NBS) is a rare bp of intron 1. Homologous recombination of the targeting
vector into the NBS1 gene results in the introduction ofautosomal recessive human disease whose clinical
features include growth retardation, EcoRI and HincII sites adjacent to the neomycin resis-
tance cassette (Figure 1a). These restriction sites wereimmunodeficiency, and increased susceptibility to
lymphoid malignancies. Cells from NBS patients used for screening embryonic stem (ES) cells by southern
blotting (Figure 1b), and the genotypes of the neomycin-exhibit g-irradiation sensitivity, S-phase
checkpoint defects, and genomic instability. resistant transformants were subsequently confirmed by
PCR analysis (Figure 1c). From two out of four indepen-Recently, it was demonstrated that this
chromosomal breakage syndrome is caused by dently targeted NBS11/2 ES cell clones, chimeric mice
were generated that transmitted the germ line NBS1 mu-mutations in the NBS1 gene that result in a total
loss of full-length NBS1 expression [1, 2]. Here we tation to offspring. NBS11/2 mice were viable and healthy,
and they grew normally. Although the cancer risk in hu-report that in contrast to the viability of NBS
patients, targeted inactivation of NBS1 in mice leads man NBS heterozygotes is high [3], 100 NBS1/2 mice did
not develop cancer spontaneously within 14 months, andto early embryonic lethality in utero and is
associated with poorly developed embryonic and tumors were not apparent in NBS11/2 mice 7 months after
treatment with 4 Gy g-irradiation (n 5 32). However, itextraembryonic tissues. Mutant blastocysts
showed greatly diminished expansion of the inner remains possible that NBS11/2 mice may develop cancer
at a more advanced age.cell mass in culture, and this finding suggests that
NBS1 mediates essential functions during
proliferation in the absence of externally induced NBS11/2 mice were fertile, but when they were interbred,
damage. Together, our results indicate that the homozygous mutants for the targeted NBS1 allele were
complex phenotypes observed in NBS patients and not found among the 312 offspring analyzed from one of
cell lines may not result from a complete inactivation the founder lines. These results indicate the embryonic
of NBS1 but may instead result from hypomorphic lethality of the NBS1-deficient phenotype (Table 1). To
truncation mutations compatible with cell viability. determine the onset of lethality, we isolated embryos at
various stages of gestation. At e7.5–e10.5 (where e 5
embryonic day), no NBS12/2 embryos were found amongAddresses: *Experimental Immunology Branch, National Cancer
the 66 analyzed. However, several decidua containingInstitute, National Institutes of Health, Bethesda, MD 20892, USA.
†Mammalian Genetics Laboratory, National Cancer Institute, National resorbed embryos were found at e7.5–e10.5 (Table 1).
Institutes of Health, Frederick, MD 20892, USA. This suggests that the death of NBS12/2 embryos occurred
before e7.5.Correspondence: Andre´ Nussenzweig
E-mail: andre_nussenzweig@nih.gov
To further investigate the nature of the lethality, we ex-
Received: 15 November 2000 amined serial sections of embryos between e5.5 and e7.5
Revised: 6 December 2000 (Figure 2). At e7.5, 5 out of 16 embryos were found toAccepted: 6 December 2000
be in an advanced stage of resorption. At e6.5, 3 out of
10 embryos were grossly smaller than their littermates,Published: 23 January 2001
and their cells appeared morphologically disorganized and
Current Biology 2001, 11:105–109 degenerated. These smaller embryos also lacked any de-
tectable structures, such as embryonic or extraembryonic0960-9822/01/$ – see front matter
ecotoderm or a preamniotic cavity (Figure 2). Even at
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e5.5, there was an overall reduction in size in 7 out of 21
embyronic sections examined (not shown). Both the timing
of this apparent developmental block and the morphologyResults and discussion
of the NBS12/2 embryos are similar to the homozygousSince it is unknown whether defects in NBS patients are
mutant phenotypes of RAD50 [4], RAD51 [5], BRCA1 [6, 7],manifestations of hypomorphic or null mutations, it is
and BRCA2 [8], which may function in similar DNA dou-possible that complete inactivation of NBS1 might reveal
ble-strand break (DSB) repair pathways [9].novel functions for this protein. We therefore decided to
target the 59 region of NBS1 to produce a null allele.
Ablation of NBS1 was achieved by the deletion of 2 kb To test whether NBS12/2 embryos survive until the blasto-
cyst stage, we isolated preimplantation embryos at e3.5of DNA spanning the NBS1 promoter, exon 1, and 700
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Figure 1
Targeting of mouse NBS1 (a) Genomic
structure of the wild-type NBS1 locus and
targeting vector. A genomic clone was isolated
from a mouse BAC library (Genome
Systems) with a 700 bp BgII/PstI probe
derived from the 59 end of mouse NBS1
cDNA. In the targeting vector and targeted
allele, the neomycin selection cassette
replaces the first NBS1 exon, including the
translation initiation codon. Homologous
recombination introduces EcoRI (E) and HincII
(H) sites, which reduces the 11 kb wild-type
EcoRI fragment and the 3.0 kb wild-type HincII
fragment to 2 kb. Four successful targeting
events were identified in 250 clones screened.
(b) Identification of NBS1 targeting in ES
cells by southern blotting. EcoRI-digested
genomic DNA from NBS11/1 and NBS11/2
ES cells were hybridized with a 300 bp PstI
probe upstream of exon 1; results were
confirmed with HincII digestion of genomic
DNA (not shown). (c) PCR screening of DNA
from ES cells and mouse tails by the use of




PCR was performed with a mixture of all three
primers. The C133/W123 combination
generates a 256 bp wild-type band, and the
C133/Mut2 combination generates a 150 bp
mutant band. Location of PCR primers is
indicated schematically in (a).
and observed them on a daily basis as they grew in culture stage. When NBS11/1 or NBS11/2 blastocysts were cul-
tured in vitro, cells from the inner cell mass (ICM) prolif-for 4 days (Figure 3a). Out of 97 embryos genotyped on
day 4, 12 were found to be NBS12/2 (Figure 3b; Table erated rapidly and formed a colony on top of the tropho-
blast giant cells (Figure 3a, upper panels). In contrast,1), and this finding indicates that at least some of the
homozygous mutant embryos developed to the blastocyst abnormal ICM development became evident in NBS12/2
Table 1
Genotypes of live births and embryos from NBS1/2 intercrosses*
Resorted or
NBS1/1 NBS1/2 NBS2/2 empty decidua Total
Live births 116 196 0 312
Embryos, e8.5–10.5 8 22 0 7 37
Embryos, e7.5 4 20 0 5 29
In vitro growth of e3.5 blastocysts after 4 days
Normal ICM 31 53 0 84
No ICM 0 1 12 18†
*The genetic background of the NBS11/2 mice is 129 3 C57BL/6, and genotyping failed for five embryos that lacked ICM at day 4 (e7.5).
all the progeny and embryos are derived from one founder line. †PCR
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embryos after 2 days in culture, when the ICM appeared forms irradiation-induced foci that associate with DSBs
until the damage is repaired [11]. Similarly, DSBs gener-smaller than the controls. These ICM from NBS12/2 em-
bryos continued to diminish in size until the majority of ated during physiological V(D)J (variable, diversity, join-
ing) recombination cause the redistribution of NBS1 tothese cells died by day 4 in culture and left behind a
monolayer of trophoblast giant cells (Figure 3a; lower sites of RAG-mediated V(D)J cleavage [12]. In NBS pa-
tient cells, which contain truncating or nonsense muta-panels). Nine out of twelve NBS12/2 embryos lacked any
detectable ICM by day 4, and the remaining three tions in NBS1, the formation of ionizing radiation-induced
Mre11/Rad50 foci and the inhibition of DNA synthesisNBS12/2 outgrowths were much smaller than those of the
controls. Efforts to generate NBS12/2 ES cell lines by in response to g-irradiation are abrogated [2, 13]. It has
been speculated that these mutations in NBS result ineither culturing NBS11/2 ES cells in high concentrations
of G418 or by retargeting NBS11/2 ES cells by using an null alleles [1, 14]. However, the data presented here
demonstrate that in contrast to the viability of NBS pa-independently derived construct conferring hygromycin
resistance also failed to generate any NBS12/2 ES cells. tients, complete loss of NBS1 in mice leads to embryonic
lethality associated with defective cellular proliferation.Thus, it appears that NBS1 is essential for growth of early
embryonic cells. Thus, we hypothesize that NBS patients may not carry
null NBS1 alleles. Rather, they may express a truncated
NBS1 protein that abrogates DSB recognition/signaling
NBS1 plays a central role in detecting and signaling the functions but that still supports viability. Consistent with
presence of DSBs, which may arise either as a result of this prediction, a 70 kDa protein, which may be an N
external damage or during normal metabolic processes terminally truncated form of NBS1, has recently been
[10]. NBS1, together with the Mre11/Rad50 complex, identified in NBS patient cells (J. H. Petrini, personal
communication).
Figure 2
A very similar scenario is observed in cells carrying muta-
tions in MRE11. Hypomorphic alleles of human MRE11
have been discovered in an ataxia telangiectasia–like dis-
order, which, like NBS, is characterized by g-radiation
sensitivity, defective cell cycle checkpoints, and increased
genomic instability [15]. However, like NBS1 and RAD50
null mutations, homozygous disruption of MRE11 results
in early embryonic lethality [16]. Recent studies in S.
cerevisiae demonstrate that MRE11 is required for sister
chromatid recombinational repair [17]. Likewise, MRE11
null chicken cells exhibit a reduced capacity for homolo-
gous recombination and undergo proliferative arrest asso-
ciated with high levels of chromosome aberrations [18].
Additionally, MRE11 complexes have been found in asso-
ciation with blocked DNA replication forks [19]. Thus,
it is possible that the failure to repair DSBs that arise
spontaneously during DNA replication in MRE112/2,
RAD502/2, or NBS12/2 embryos might lead to massive cell
death during embryogenesis. This embryonic lethality
appears not to be rescued by the loss of p53, as we have
been unable to obtain live NBS12/2p532/2 progeny (n 5
100) by crossing the NBS1 defect into the p532/2 back-
ground. Similarly, the embryonic lethality phenotype
caused by deficiencies in RAD51, BRCA1, and BRCA2
could not be rescued in a p53 null background [5, 20, 21].
These data raise the possibility that NBS1 may function
in similar recombinational repair pathways that are re-
quired for maintaining genomic stability in the absenceHistological sections of embryos grown in utero to e7.5. E6.5 and
of exogenous damage.e7.5 decidua from NBS11/2 intercrosses were sectioned and
stained with hematoxylin and eosin. A midsagital section is shown for
normal and presumed mutant embryos. Abbreviations are as follows: ee, Acknowledgementsembryonic ectoderm; xe, extraembryonic ectoderm; pac, preamniotic
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cavity. Scale bars represent 100 mm. Deng, and Linda Lowe for suggestions, and Alfred Singer and Michael Kuehn
for critical reading of the manuscript.
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Figure 3
Defective growth of NBS12/2 blastocysts in vitro. (a) E3.5 blastocysts ml lysis buffer (100 mM KCl, 10 mM Tris HCl, 2.5 mM MgCl2, 0.45%
were isolated from NBS11/2 intercrosses and cultured in 96 well Tween 20, 0.45% NP40, and 1 mg/ml proteinase K) for 4–5 hr at
plates. Pictures were taken on a daily basis with a phase contrast 558C. DNA samples (3–5 ml) were used for genotyping. In the first
microscope (Zeiss Axiovert 100) prior to genotyping by PCR. The round of PCR, a common primer, C1400 (59-GGCTAAGA
upper panel shows growth of NBS11/2 blastocysts, and the lower TGTATTGCTCCG-39), a wild-type specific primer, W210 (59-
panel is an example of NBS12/2 blastocyst outgrowth. Inner cell GGATCTGGGAAGCTAAAGTATG-39), and a mutant primer, 3PNT
mass (ICM) and trophoblast giant cells (TGC) are indicated. The scale (59- TAAAGCGCATG CTCCAGACT-39) were used. For the second
bar represents 100 mm. (b) Examples of PCR genotyping of blastocysts round of PCR, primers Com133, W123, and Mut2 (indicated in
after 4 days in vitro culture. A nested PCR strategy was used. DNA Figure 1) were used to amplify both wild-type and mutant fragments.
preparation was by the incubation of individual blastocysts with 20
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